Healthcare expenditures are at 5.2% of the GDP, of which 39% comes from government funding, 59% from patient contributions and another 2% from charity.

The main government bodies managing Egypt’s healthcare system are the Ministry of Health (MoH) and the Health Insurance Organization (HIO).The national organization is replicated at each governorate level. In Egypt, health services are delivered by a multitude of public service providers (MoH, ministries of Higher Education, Defense, the Interior, etc.), the Health Insurance Organization (HIO), Non-Governmental Organizations (NGOs) and an expanding network of private practitioners and medical facilities. Even though presence of multiple providers could imply competitive services, in reality, there is very limited or no performance assessment mechanisms or quality assurance.

The deterioration of public health service providers made the private ones particularly appealing; in 2008/9 private, out-of-pocket health expenditures reached 72% of total health spending by households, compared to 60% in 2001/02.

Below are some basic figures of the market:

•Market size: 3billion USD ,12% annual growth

•Total manufacturer: 140 around, produce over 500 products .  GSK , pfizer, Novartis ,etc. around 5 Indian have local companies. Such as Ranbaxy ,etc.

•Local API – 2 only .

•Local / import : 50:50

•Public / private: 30:70

•Generics /Originator:  90:10 by volume

•OTC/Prescription Drug: 20: 80

•Governmental owned : around 10 companies .

•Import API for local production could have 15% tax free.

•IP in Egypt : No IP protection

 •Healthcare system:  The employee could choose different levels which would get different coverage of free medicines and services provide by public hospitals